Related Experiment Video
Updated: Jan 4, 2026

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
Published on: April 27, 2021
Mast cell mediators in relation to dengue severity: A systematic review and meta-analysis
Nourin Ali Sherif1,2, Ahmad Helmy Zayan2,3, Aya Hesham Elkady2,4
1Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Background:
Degranulation of mast cells (MCs) releases several mediators such as vascular endothelial growth factor (VEGF), chymase, tryptase, histamine, and cytokines, which all have important roles in the severity of dengue infection. We aimed to investigate the role of MCs in severity of dengue.
Methods:
We searched for relevant studies in 10 databases on 15 August 2016. Meta-analysis (MA) was conducted by R version 3.5.0.
Results:
We included 24 studies. in vivo and in vitro studies showed higher MC products released from infected mice/cells with dengue virus. In addition, when administering MC stabilizers or antihistaminic drugs, there was a decrease in vascular/capillary permeability. In human and at early stages, studies revealed an insignificant difference in VEGF levels in dengue fever (DF) versus dengue hemorrhagic fever (DHF) (standardized mean difference [SMD] 0.145; 95% confidence interval [CI], -0.348-0.638). Meanwhile, at acute stages and compared with healthy controls, high heterogeneity with an inconclusive difference in VEGF levels were noted in DF and DHF. However, pooled serum and plasma levels of VEGF were increased significantly in dengue shock syndrome (DSS) versus healthy controls (SMD 0.65; 95% CI, 0.3-0.95). There were also significantly higher chymase levels in DHF patients compared with DF during the acute phase (MD -6.531; 95% CI, -12.2 to -0.9).
Conclusion:
VEGF and chymase levels are mediators in dengue pathogenesis. However, limited data were available to support their role in severe dengue cases. Further studies are needed to evaluate the function of other mediators in dengue severity.
Insights
Mast cells (MCs) release mediators like VEGF and chymase, influencing dengue severity. While VEGF levels showed no significant difference in early dengue fever stages, chymase was higher in severe dengue hemorrhagic fever.
Area of Science:
- Immunology
- Virology
- Pathogenesis
Background:
- Mast cells (MCs) degranulate, releasing mediators like vascular endothelial growth factor (VEGF), chymase, tryptase, histamine, and cytokines.
- These mediators play crucial roles in the severity of dengue virus infections.
Purpose of the Study:
- To investigate the role of mast cells (MCs) and their mediators in the severity of dengue infection.
Main Methods:
- A meta-analysis was conducted using data from 24 relevant in vivo and in vitro studies.
- Searches were performed across 10 databases up to August 2016, with analysis using R version 3.5.0.
Main Results:
- Infected mice/cells showed higher MC product release.
- MC stabilizers and antihistamines reduced vascular permeability.
- VEGF levels were not significantly different in early dengue fever (DF) vs. dengue hemorrhagic fever (DHF).
- VEGF levels were significantly increased in dengue shock syndrome (DSS) compared to controls.
- Chymase levels were significantly higher in DHF compared to DF during the acute phase.
Conclusions:
- VEGF and chymase are mediators in dengue pathogenesis.
- Limited data currently support their definitive role in severe dengue cases.
- Further research is required to fully elucidate the function of other mediators in dengue severity.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Drug Reactions
Allergic Reactions
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

